341 related articles for article (PubMed ID: 32138562)
41. Prospects and challenges of multi-omics data integration in toxicology.
Canzler S; Schor J; Busch W; Schubert K; Rolle-Kampczyk UE; Seitz H; Kamp H; von Bergen M; Buesen R; Hackermüller J
Arch Toxicol; 2020 Feb; 94(2):371-388. PubMed ID: 32034435
[TBL] [Abstract][Full Text] [Related]
42. CD4
Kato R; Sumitomo S; Tsuchida Y; Tsuchiya H; Nakachi S; Sakurai K; Hanata N; Nagafuchi Y; Kubo K; Tateishi S; Kanda H; Okamura T; Yamamoto K; Fujio K
Front Immunol; 2019; 10():1619. PubMed ID: 31354747
[TBL] [Abstract][Full Text] [Related]
43. Tools for fundamental understanding of systemic lupus erythematosus.
Kumar H
Int Rev Immunol; 2020; 39(4):151-152. PubMed ID: 32687460
[No Abstract] [Full Text] [Related]
44. Integration of multi-omics analysis reveals metabolic alterations of B lymphocytes in systemic lupus erythematosus.
Iperi C; Fernández-Ochoa Á; Pers JO; Barturen G; Alarcón-Riquelme M; ; Quirantes-Piné R; Borrás-Linares I; Segura-Carretero A; Cornec D; Bordron A; Jamin C
Clin Immunol; 2024 Jul; 264():110243. PubMed ID: 38735509
[TBL] [Abstract][Full Text] [Related]
45. Multi-omics approaches to human biological age estimation.
Solovev I; Shaposhnikov M; Moskalev A
Mech Ageing Dev; 2020 Jan; 185():111192. PubMed ID: 31786174
[TBL] [Abstract][Full Text] [Related]
46. Clinical application of protein biomarkers in lupus erythematosus and lupus nephritis.
Qi S; Chen Q; Xu D; Xie N; Dai Y
Lupus; 2018 Sep; 27(10):1582-1590. PubMed ID: 29720035
[TBL] [Abstract][Full Text] [Related]
47. Increase of MZB1 in B cells in systemic lupus erythematosus: proteomic analysis of biopsied lymph nodes.
Miyagawa-Hayashino A; Yoshifuji H; Kitagori K; Ito S; Oku T; Hirayama Y; Salah A; Nakajima T; Kiso K; Yamada N; Haga H; Tsuruyama T
Arthritis Res Ther; 2018 Jan; 20(1):13. PubMed ID: 29382365
[TBL] [Abstract][Full Text] [Related]
48. Integrated Multi-Omics for Novel Aging Biomarkers and Antiaging Targets.
Wu L; Xie X; Liang T; Ma J; Yang L; Yang J; Li L; Xi Y; Li H; Zhang J; Chen X; Ding Y; Wu Q
Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053186
[TBL] [Abstract][Full Text] [Related]
49. Metabolic Profiling of Systemic Lupus Erythematosus and Comparison with Primary Sjögren's Syndrome and Systemic Sclerosis.
Bengtsson AA; Trygg J; Wuttge DM; Sturfelt G; Theander E; Donten M; Moritz T; Sennbro CJ; Torell F; Lood C; Surowiec I; Rännar S; Lundstedt T
PLoS One; 2016; 11(7):e0159384. PubMed ID: 27441838
[TBL] [Abstract][Full Text] [Related]
50. Identification of potential biomarkers for systemic lupus erythematosus diagnosis using two-dimensional differential gel electrophoresis (2D-DIGE) and mass spectrometry.
Ferreira TAR; de Andrade HM; de Pádua PM; Carvalho MDG; Pires SDF; Oliveira IHR; Lima BSS; Fialho Júnior LC; Cicarini WB; Chapeourouge DA; Perales JH; Guimarães TMPD; Toledo VPCP
Autoimmunity; 2017 Jun; 50(4):247-256. PubMed ID: 28675715
[TBL] [Abstract][Full Text] [Related]
51. Circulating microparticles in systemic Lupus Erythematosus.
Nielsen CT
Dan Med J; 2012 Nov; 59(11):B4548. PubMed ID: 23171755
[TBL] [Abstract][Full Text] [Related]
52. Leveraging Heterogeneity in Systemic Lupus Erythematosus for New Therapies.
Allen ME; Rus V; Szeto GL
Trends Mol Med; 2021 Feb; 27(2):152-171. PubMed ID: 33046407
[TBL] [Abstract][Full Text] [Related]
53. Systemic lupus erythematosus: nothing stale her infinite variety.
Oku K; Atsumi T
Mod Rheumatol; 2018 Sep; 28(5):758-765. PubMed ID: 29947275
[TBL] [Abstract][Full Text] [Related]
54. The critical role of epigenetics in systemic lupus erythematosus and autoimmunity.
Long H; Yin H; Wang L; Gershwin ME; Lu Q
J Autoimmun; 2016 Nov; 74():118-138. PubMed ID: 27396525
[TBL] [Abstract][Full Text] [Related]
55. ¹H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus.
Ouyang X; Dai Y; Wen JL; Wang LX
Lupus; 2011 Nov; 20(13):1411-20. PubMed ID: 21976403
[TBL] [Abstract][Full Text] [Related]
56. SLE and purine metabolizing ecto-enzymes.
Cronstein BN
EBioMedicine; 2021 Dec; 74():103688. PubMed ID: 34773894
[No Abstract] [Full Text] [Related]
57. Gene expression profiling in the study of the pathogenesis of systemic lupus erythematosus.
Qing X; Putterman C
Autoimmun Rev; 2004 Nov; 3(7-8):505-9. PubMed ID: 15546798
[TBL] [Abstract][Full Text] [Related]
58. Leveraging Multilayered "Omics" Data for Atopic Dermatitis: A Road Map to Precision Medicine.
Ghosh D; Bernstein JA; Khurana Hershey GK; Rothenberg ME; Mersha TB
Front Immunol; 2018; 9():2727. PubMed ID: 30631320
[TBL] [Abstract][Full Text] [Related]
59. Cytokines and MicroRNAs as Candidate Biomarkers for Systemic Lupus Erythematosus.
Stypińska B; Paradowska-Gorycka A
Int J Mol Sci; 2015 Oct; 16(10):24194-218. PubMed ID: 26473848
[TBL] [Abstract][Full Text] [Related]
60. Systemic lupus erythematosus: immunopathogenesis and novel therapeutic targets.
Beccastrini E; D'Elios MM; Emmi G; Silvestri E; Squatrito D; Prisco D; Emmi L
Int J Immunopathol Pharmacol; 2013; 26(3):585-96. PubMed ID: 24067455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
